Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Tzu Tai

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
Blood|July 12, 2003
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistanceDharminder Chauhan, Guilan Li, Teru Hideshima, et al.
Blood Advances|September 8, 2020
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical modelsShih-Feng Cho, Liang Lin, Lijie Xing, et al.
Cancer Research|July 5, 2006
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironmentYu-Tzu Tai, Xian-Feng Li, Iris Breitkreutz, et al.
Blood|December 8, 2009
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcomeJames J Driscoll, Dheeraj Pelluru, Konstantinos Lefkimmiatis, et al.
Communications Biology|May 25, 2021
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinomaSubodh Kumar, Leutz Buon, Srikanth Talluri, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Blood|July 10, 2009
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significanceSimona Blotta, Pierfrancesco Tassone, Rao H Prabhala, et al.
The Journal of Biological Chemistry|December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cellsKlaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myelomaMariateresa Fulciniti, Teru Hideshima, Claudine Vermot-Desroches, et al.
Blood|June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myelomaLaurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
Blood|July 12, 2003
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistanceDharminder Chauhan, Guilan Li, Teru Hideshima, et al.
Blood Advances|September 8, 2020
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical modelsShih-Feng Cho, Liang Lin, Lijie Xing, et al.
Cancer Research|July 5, 2006
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironmentYu-Tzu Tai, Xian-Feng Li, Iris Breitkreutz, et al.
Blood|December 8, 2009
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcomeJames J Driscoll, Dheeraj Pelluru, Konstantinos Lefkimmiatis, et al.
Communications Biology|May 25, 2021
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinomaSubodh Kumar, Leutz Buon, Srikanth Talluri, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Blood|July 10, 2009
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significanceSimona Blotta, Pierfrancesco Tassone, Rao H Prabhala, et al.
The Journal of Biological Chemistry|December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cellsKlaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myelomaMariateresa Fulciniti, Teru Hideshima, Claudine Vermot-Desroches, et al.
Blood|June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myelomaLaurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.
Pageof 22